PARTNERS IN PHARMA Trademark

Trademark Overview

On Monday, July 26, 2010, a trademark application was filed for PARTNERS IN PHARMA with the United States Patent and Trademark Office. The USPTO has given the PARTNERS IN PHARMA trademark a serial number of 85092585. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, September 3, 2020. This trademark is owned by Partners in Pharma, LLC. The PARTNERS IN PHARMA trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business management advisory and consulting services to large business entities and operations in the global pharmaceutical industry, including licensing, joint ventures and acquisitions
partners in pharma

General Information

Serial Number85092585
Word MarkPARTNERS IN PHARMA
Filing DateMonday, July 26, 2010
Status800 - REGISTERED AND RENEWED
Status DateThursday, September 3, 2020
Registration Number4001274
Registration DateTuesday, July 26, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2011

Trademark Statements

Goods and ServicesBusiness management advisory and consulting services to large business entities and operations in the global pharmaceutical industry, including licensing, joint ventures and acquisitions
Disclaimer with Predetermined Text"PHARMA"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, July 29, 2010
Primary Code035
First Use Anywhere DateFriday, July 16, 2010
First Use In Commerce DateFriday, July 16, 2010

Trademark Owner History

Party NamePartners in Pharma, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressGladstone, NJ 07934
Party NamePartners in Pharma, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGladstone, NJ 07934
Party NamePartners in Pharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGladstone, NJ 07934

Trademark Events

Event DateEvent Description
Tuesday, May 16, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 16, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 3, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, September 3, 2020REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, September 3, 2020REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, September 2, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 27, 2020TEAS SECTION 8 & 9 RECEIVED
Sunday, July 26, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, April 7, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, April 7, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, April 7, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, February 8, 2017TEAS SECTION 8 & 15 RECEIVED
Wednesday, February 8, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 26, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, May 10, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 10, 2011PUBLISHED FOR OPPOSITION
Thursday, April 7, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 6, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 14, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 14, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 8, 2011ASSIGNED TO LIE
Thursday, February 24, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 9, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 9, 2010NON-FINAL ACTION E-MAILED
Tuesday, November 9, 2010NON-FINAL ACTION WRITTEN
Tuesday, November 9, 2010ASSIGNED TO EXAMINER
Thursday, July 29, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 29, 2010NEW APPLICATION ENTERED

Related Keywords

pharma partners business including industry licensing joint acquisitions ventures pharmaceutical operations advisory